Related Experiment Video
Updated: Feb 8, 2026

Using RNA-interference to Investigate the Innate Immune Response in Mouse Macrophages
Published on: November 3, 2014
MCPIP1 negatively regulate cellular antiviral innate immune responses through DUB and disruption of TRAF3-TBK1-IKKε
Xiaojuan Chen1, Qian Zhao1, Qing Xie1
1Division of Infection and Immunity, Department of Biological Technology, Beijing Institute of Radiation Medicine, Beijing, 100850, China.
Abstract:
IFNβ innate immune plays an essential role in antiviral immune. Previous reports suggested that many important regulatory proteins in innate immune pathway may be modified by ubiquitin and that many de-ubiquitination (DUB) proteins may affect immunity. Monocyte chemotactic protein-inducing protein 1 (MCPIP1), one of the CCCH Zn finger-containing proteins, was reported to have DUB function, but its effect on IFNβ innate immune was not fully understood. In this study, we uncovered a novel mechanism that may explain how MCPIP1 efficiently inhibits IFNβ innate immune. It was found that MCPIP1 negatively regulates the IFNβ expression activated by RIG-I, STING, TBK1, IRF3. Furthermore, MCPIP1 inhibits the nuclear translocation of IRF3 upon stimulation with virus, which plays a key role in type I IFN expression. Additionally, MCPIP1 interacts with important modulators of IFNβ expression pathway including IPS1, TRAF3, TBK1 and IKKε. Meanwhile, the interaction between the components in TRAF3-TBK1-IKKε complex was disrupted by MCPIP1. These results collectively suggest MCPIP1 as an innate immune regulator encoded by the host and point to a new mechanism through which MCPIP1 negatively regulates IRF3 activation and type I IFNβ expression.
Insights
Monocyte chemotactic protein-inducing protein 1 (MCPIP1) inhibits the innate immune response by blocking interferon-beta (IFNβ) expression. This protein disrupts the activation and nuclear translocation of IRF3, a key regulator of antiviral immunity.
Area of Science:
- Immunology
- Molecular Biology
- Virology
Background:
- Interferon-beta (IFNβ) is crucial for antiviral innate immunity.
- Ubiquitination and de-ubiquitination (DUB) pathways regulate innate immune proteins.
- Monocyte chemotactic protein-inducing protein 1 (MCPIP1) possesses DUB activity, but its role in IFNβ immunity is unclear.
Purpose of the Study:
- To elucidate the mechanism by which MCPIP1 regulates IFNβ innate immune response.
- To investigate MCPIP1's effect on key signaling molecules involved in IFNβ production.
Main Methods:
- Investigated MCPIP1's effect on IFNβ expression induced by RIG-I, STING, TBK1, and IRF3.
- Assessed MCPIP1's impact on IRF3 nuclear translocation.
- Analyzed MCPIP1 interactions with IPS1, TRAF3, TBK1, and IKKε.
- Examined MCPIP1's disruption of the TRAF3-TBK1-IKKε complex.
Main Results:
- MCPIP1 negatively regulates IFNβ expression activated by RIG-I, STING, TBK1, and IRF3.
- MCPIP1 inhibits the virus-induced nuclear translocation of IRF3, a critical step for type I IFN expression.
- MCPIP1 interacts with IPS1, TRAF3, TBK1, and IKKε, disrupting the TRAF3-TBK1-IKKε complex.
Conclusions:
- MCPIP1 acts as a host-encoded innate immune regulator.
- MCPIP1 inhibits type I IFNβ expression by negatively regulating IRF3 activation.
- A novel mechanism of MCPIP1-mediated inhibition of IFNβ innate immunity is described.
Related Concept Videos
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Negative Regulator Molecules
Humoral Immune Responses
Introduction to Innate and Adaptive Immunity
Innate immunity is the body's natural, nonspecific defense system that acts quickly to protect against pathogens. It incorporates physical barriers like skin and mucous membranes and cellular elements such as phagocytes and natural killer cells. This part of our immune system provides an immediate,...
What is the Immune System?
Inflammatory Response I: Vascular and Cellular

